Research overview · Repair and metabolic peptides
CJC-1295 DAC (5mg)
What is CJC-1295 DAC (5mg)?
CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH). The "DAC" designation refers to a Drug Affinity Complex modification that extends the molecule's circulating half-life in research models by binding to serum albumin.
It is studied in endocrinology research for its interaction with GHRH receptors and the somatotropic axis. This product is supplied for laboratory research use only and is not for human or veterinary use.
Documentation
Documentation status for CJC-1295 DAC (5mg) is shown on its product record.
Frequently asked questions
- What is CJC-1295 DAC (5mg)?
- CJC-1295 DAC (5mg) is a research compound in the Repair and metabolic peptides category supplied by East Coast Labs strictly for laboratory research use only. It is not for human or veterinary use.
- Is CJC-1295 DAC (5mg) for human use?
- No. CJC-1295 DAC (5mg) is supplied for laboratory research use only and is not intended for human or veterinary use, consumption, or therapeutic application.
Selected research literature
Peer-reviewed references retrieved from PubMed, provided for research context. These are links to published studies and do not constitute a health claim about this product.
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab 2005. PubMed 16352683 DOI
Citation data via PubMed (U.S. National Library of Medicine).